Common use of Certain Data Clause in Contracts

Certain Data. The Parties recognize the need for Adimab to disclose the general capabilities of the Adimab Platform Technology. In connection therewith, notwithstanding this Article 6 (Confidentiality; Publicity), without disclosing Scholar Rock’s identity, the identity of the Target (although the class of Target may be disclosed as protein to protein complexes), or the sequence of any Program Antibody, Adimab shall be entitled to disclose generally Program Antibody attributes and Program Inventions, including the following: (a) Program Antibody binding affinities (kD), (b) expression range regarding Program Antibodies, (c) germline distribution of Program Antibodies, (d) Program Antibody format (i.e., monoclonal, ▇▇▇▇▇▇▇▇ bispecific, etc.), and (e) stage of development of Program-Benefited Antibodies.

Certain Data. The Parties recognize the need for Adimab to disclose the general capabilities of the Adimab Platform Technology. In connection therewith, notwithstanding this Article 6 (Confidentiality; Publicity), without disclosing Scholar RockiTeos’s identity, the identity of the Target (although the class of protein of the Target may be disclosed as protein to protein complexesdisclosed), or the sequence of any Program Antibody, Adimab shall be entitled to disclose generally Program Antibody attributes and Program InventionsKnow-How, including the following: (a) Program Antibody binding affinities (kD), (b) expression range regarding Program Antibodies, (c) germline distribution of Program Antibodies, and (d) Program Antibody format (i.e., monoclonal, ▇▇▇▇▇▇▇▇ bispecific, etc.), and (e) stage of development of Program-Benefited Antibodies.